• Glucose Tolerance Test, 2 Hour Post-75g Oral Ingestion
  • Biopsy, Liver
  • Cytochrome P450 1B1 (CYP1B1) Genotyping
  • SERPINA1 Gene Mutation Analysis
  • Delta-type Opioid Receptor 1 (OPRD1) Genotyping
  • Cortisol, Salivary
  • Ammonia, Urine
  • Low Density Lipoprotein (LDL, VLDL)
  • Treponema pallidum Antigen, Direct Fluorescent Antibody (DFA)
  • Tzanck Smear, Cytology
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prosigna Breast Cancer Prognostic Gene Signature
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Prosigna Breast Cancer Prognostic Gene Signature
Medical Test

Diseases (2)
Access to Prosigna Breast Cancer Prognostic Gene Signature is restricted.
Loading...